Literature DB >> 2842977

Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

D B Boyle1, B E Coupar.   

Abstract

Plasmid vectors have been constructed which allow the construction of infectious fowlpox virus (FPV) recombinants expressing foreign genes. The foreign genes were inserted within the thymidine kinase (TK) gene of FPV contained in these vectors. To facilitate the selection of recombinants the Escherichia coli xanthine guanine phosphoribosyl transferase (Ecogpt) gene was developed as a dominant selectable marker. This marker operates in a wide variety of cell types and obviates the need for TK- cell lines for selection of TK- recombinants when foreign genes have been inserted within the TK gene of FPV. The general approach adopted was to construct plasmid vectors in which the FPV TK was interrupted by the Ecogpt gene under the control of a poxvirus promoter in tandem with a gene of interest under the control of another poxvirus promoter. Selection of viruses expressing the Ecogpt gene simultaneously selects for recombinants carrying both the Ecogpt gene and the gene of interest. Using this approach a series of plasmid vectors was constructed in which the FPV TK gene was interrupted by the Ecogpt gene under the control of the P7.5 vaccinia virus promoter in tandem with the A/PR/8/34 haemagglutinin gene under the control of the PL11 vaccinia virus promoter. A recombinant FPV constructed using these plasmids had the expected genome arrangement, expressed influenza haemagglutinin, and induced haemagglutination-inhibiting antibodies when inoculated into chickens. These techniques should allow the construction of a variety of recombinant FPVs expressing poultry vaccine antigens. Such recombinants should be a very cost-effective means of delivering vaccines to poultry.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842977     DOI: 10.1016/0168-1702(88)90075-5

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  21 in total

1.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 2.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.

Authors:  K H Leong; A J Ramsay; D B Boyle; I A Ramshaw
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Vaccinia virus expression and sequence of an avian influenza nucleoprotein gene: potential use in diagnosis.

Authors:  V R Harley; P J Hudson; B E Coupar; P W Selleck; H Westbury; D B Boyle
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 5.  Reflections on the early development of poxvirus vectors.

Authors:  Bernard Moss
Journal:  Vaccine       Date:  2013-04-10       Impact factor: 3.641

6.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

Authors:  H G Heine; D B Boyle
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

9.  Transient expression assay in a baculovirus system using firefly luciferase gene as a reporter.

Authors:  T N Kopylova-Sviridova; V I Krauzova; T M Timiryasova; T V Gorelova; N G Shuppe; I Fodor
Journal:  Virus Genes       Date:  1992-11       Impact factor: 2.332

10.  Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants.

Authors:  D B Boyle
Journal:  Virus Genes       Date:  1992-08       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.